31P A study to assess the efficacy and feasibility of adding pioglitazone to imatinib in patients of CML with suboptimal response in a resource-limited setting
2020 · Annals of Oncology · 3 citations
https://doi.org/10.1016/j.annonc.2020.01.032
K
K.N. Lokesh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
369
Citations
10
h-index
15
i10-index
K.N. Lokesh is an academic researcher from Kidwai Memorial Institute of Oncology. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 10, co-authored 91 publications.
Papers by this author
worksFollicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report
2020 · Journal of the Egyptian National Cancer Institute · 2 citations
https://doi.org/10.1186/s43046-020-00035-3
Pre-phase strategy to mitigate first cycle effect in diffuse large B cell lymphoma
2022 · Journal of the Egyptian National Cancer Institute · 1 citations
https://doi.org/10.1186/s43046-022-00116-5
30P Pan-immune inflammation value (PIV): A predictive marker of response to neo-adjuvant chemotherapy (NACT) in locally advanced breast cancer (LABC)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.051
EP.12.33 Retrospective Analysis of Adenocarcinoma of Lungs From Medical Oncology Clinic in Eastern India
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.09.1563
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat